Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 31;11:518. doi: 10.3389/fimmu.2020.00518

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Zhang, Lu, Wang, Liu, Chen, Shen, Luo, Xu, Peng, Luo, Huang, Wu, Zheng, Yi, Chen and Xu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

BTLA⁺ mDCs in active TB showed an increase in CCR7⁺ cell subsets. The expression of the CCR7 in DCs was determined by flow cytometry (n = 12). The gating strategy is shown in Figure S1. (A,B) show the positive rate (%) of CCR7 expression between BTLA⁺ DCs and BTLA⁻ DCs in HCs. (C) and (D) show the MFI of CCR7 expression between BTLA⁺ DCs and BTLA⁻ DCs in HCs. (E,F) show the positive rate (%) of CCR7 expression between BTLA⁺ DCs and BTLA⁻ DCs in APT patients. (G,H) show the MFI of CCR7 expression between BTLA⁺ DCs and BTLA⁻ DCs in APT patients. (I,J) show the positive rate (%) (I) and MFI (J) of CCR7 expression in BTLA⁺ tDCs/mDCs/pDCs between HCs and APT patients. (K,L) show the mean frequency (%) (K) and MFI (L) of CCR7 expression in BTLA⁻ tDCs and mDCs between HCs and APT patients. The P-value is shown in each column (Student t-test). ^*P < 0.05, ^***P < 0.001.